# Standard Versus High Dose Inactivated Influenza Vaccine in RA

> **NCT02936180** · PHASE4 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 279 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** HD-TIV
- **BIOLOGICAL:** SD-QIV

## Key facts

- **NCT ID:** NCT02936180
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-07
- **Final completion:** 2018-12
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936180, "Standard Versus High Dose Inactivated Influenza Vaccine in RA". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02936180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*